Show simple item record

Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals

dc.contributor.authorTabak, Fehmi
dc.contributor.authorMete, Bilgul
dc.contributor.authorOzaras, Resat
dc.date.accessioned2021-03-03T17:23:36Z
dc.date.available2021-03-03T17:23:36Z
dc.date.issued2017
dc.identifier.citationOzaras R., Mete B., Tabak F., "Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals", CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, cilt.15, sa.4, ss.605, 2017
dc.identifier.issn1542-3565
dc.identifier.othervv_1032021
dc.identifier.otherav_497c95c5-d0bf-4061-a073-1d74c29969c2
dc.identifier.urihttp://hdl.handle.net/20.500.12627/52860
dc.identifier.urihttps://doi.org/10.1016/j.cgh.2016.11.030
dc.language.isoeng
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.titleOccult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals
dc.typeMakale
dc.relation.journalCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
dc.contributor.departmentİstanbul Üniversitesi , Cerrahpaşa Tıp Fakültesi , Enfeksiyon Hastalıkları
dc.identifier.volume15
dc.identifier.issue4
dc.identifier.startpage605
dc.identifier.endpage605
dc.contributor.firstauthorID241791


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record